{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "b3345d7c-8b45-4ac0-9e09-ed6b50159f4b",
   "metadata": {},
   "source": [
    "Ein Jupyter Notebook erstellen und die zwei Datensätze (train & test) via Pandas einlesen, Datensätze zusammenführen, 200 zufällige Papers auswählen."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "25cbc915-6f47-45d7-8f50-cea5ef3780a2",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "3fefe66f-5773-45e0-b5ed-d28dd29a6c5f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Datensätze importieren\n",
    "test = pd.read_csv(\"C:/Users/Julia/Desktop/Masterarbeit/Full Dataset/metastatic_local_test.csv\")\n",
    "train = pd.read_csv(\"C:/Users/Julia/Desktop/Masterarbeit/Full Dataset/metastatic_local_train.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "a3501bc3-ce96-4481-ab65-da127d1cbe5c",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Datensätze zusammenführen\n",
    "full = pd.concat([test, train])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "1cfa24c5-04b7-4c36-8faa-a331cba125b0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>doi</th>\n",
       "      <th>date</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>abstract_conclusions</th>\n",
       "      <th>abstract_introduction</th>\n",
       "      <th>abstract_methods</th>\n",
       "      <th>abstract_results</th>\n",
       "      <th>text</th>\n",
       "      <th>_input_hash</th>\n",
       "      <th>...</th>\n",
       "      <th>options</th>\n",
       "      <th>_view_id</th>\n",
       "      <th>config</th>\n",
       "      <th>answer</th>\n",
       "      <th>_timestamp</th>\n",
       "      <th>_annotator_id</th>\n",
       "      <th>_session_id</th>\n",
       "      <th>tumor_type</th>\n",
       "      <th>family</th>\n",
       "      <th>accept</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>492</th>\n",
       "      <td>10.1016/S1470-2045(19)30326-2</td>\n",
       "      <td>8/1/19</td>\n",
       "      <td>NBTXR3, a first-in-class radioenhancer hafnium...</td>\n",
       "      <td>BACKGROUND: Pathological complete response to ...</td>\n",
       "      <td>INTERPRETATION: This trial validates the mode ...</td>\n",
       "      <td>BACKGROUND: Pathological complete response to ...</td>\n",
       "      <td>METHODS: Act.In.Sarc is a phase 2-3 randomised...</td>\n",
       "      <td>FINDINGS: Between March 3, 2015, and Nov 21, 2...</td>\n",
       "      <td>NBTXR3, a first-in-class radioenhancer hafnium...</td>\n",
       "      <td>833943430</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1714942341</td>\n",
       "      <td>2024-05-05_22-27-48</td>\n",
       "      <td>2024-05-05_22-27-48</td>\n",
       "      <td>['Sarcoma']</td>\n",
       "      <td>Skin/Soft tissue</td>\n",
       "      <td>['LOCAL']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>495</th>\n",
       "      <td>10.1056/NEJMoa2115022</td>\n",
       "      <td>3/24/22</td>\n",
       "      <td>Trastuzumab Deruxtecan versus Trastuzumab Emta...</td>\n",
       "      <td>BACKGROUND: Trastuzumab emtansine is the curre...</td>\n",
       "      <td>CONCLUSIONS: Among patients with HER2-positive...</td>\n",
       "      <td>BACKGROUND: Trastuzumab emtansine is the curre...</td>\n",
       "      <td>METHODS: We conducted a phase 3, multicenter, ...</td>\n",
       "      <td>RESULTS: Among 524 randomly assigned patients,...</td>\n",
       "      <td>Trastuzumab Deruxtecan versus Trastuzumab Emta...</td>\n",
       "      <td>-362049598</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1714933145</td>\n",
       "      <td>2024-05-05_10-26-22</td>\n",
       "      <td>2024-05-05_10-26-22</td>\n",
       "      <td>['Breast']</td>\n",
       "      <td>Breast/Gynecological</td>\n",
       "      <td>['METASTATIC']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>496</th>\n",
       "      <td>10.1016/S1470-2045(18)30448-0</td>\n",
       "      <td>10/1/18</td>\n",
       "      <td>Near-infrared fluorescence for detection of se...</td>\n",
       "      <td>BACKGROUND: Accurate identification of sentine...</td>\n",
       "      <td>INTERPRETATION: Indocyanine green dye with nea...</td>\n",
       "      <td>BACKGROUND: Accurate identification of sentine...</td>\n",
       "      <td>METHODS: In this non-inferiority, within-patie...</td>\n",
       "      <td>FINDINGS: Between Dec 21, 2015, and June 19, 2...</td>\n",
       "      <td>Near-infrared fluorescence for detection of se...</td>\n",
       "      <td>-1854340481</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1714941168</td>\n",
       "      <td>2024-05-05_22-27-48</td>\n",
       "      <td>2024-05-05_22-27-48</td>\n",
       "      <td>['Cervix', 'Endometrial']</td>\n",
       "      <td>Breast/Gynecological</td>\n",
       "      <td>['LOCAL']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>497</th>\n",
       "      <td>10.1056/NEJMoa2005493</td>\n",
       "      <td>9/17/20</td>\n",
       "      <td>Five-Year Analysis of Adjuvant Dabrafenib plus...</td>\n",
       "      <td>BACKGROUND: In the previously reported primary...</td>\n",
       "      <td>CONCLUSIONS: In the 5-year follow-up of a phas...</td>\n",
       "      <td>BACKGROUND: In the previously reported primary...</td>\n",
       "      <td>METHODS: We randomly assigned 870 patients who...</td>\n",
       "      <td>RESULTS: The minimum duration of follow-up was...</td>\n",
       "      <td>Five-Year Analysis of Adjuvant Dabrafenib plus...</td>\n",
       "      <td>800185485</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1714941157</td>\n",
       "      <td>2024-05-05_22-27-48</td>\n",
       "      <td>2024-05-05_22-27-48</td>\n",
       "      <td>['Melanoma']</td>\n",
       "      <td>Skin/Soft tissue</td>\n",
       "      <td>['LOCAL']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>499</th>\n",
       "      <td>10.1016/S1470-2045(16)30104-8</td>\n",
       "      <td>8/1/16</td>\n",
       "      <td>Combined chemotherapy with cisplatin, etoposid...</td>\n",
       "      <td>BACKGROUND: Etoposide and irinotecan are key d...</td>\n",
       "      <td>INTERPRETATION: Combination chemotherapy with ...</td>\n",
       "      <td>BACKGROUND: Etoposide and irinotecan are key d...</td>\n",
       "      <td>METHODS: We did this open-label, multicentre, ...</td>\n",
       "      <td>FINDINGS: Between Sept 20, 2007, and Nov 30, 2...</td>\n",
       "      <td>Combined chemotherapy with cisplatin, etoposid...</td>\n",
       "      <td>373127467</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1714844497</td>\n",
       "      <td>2024-05-04_18-55-46</td>\n",
       "      <td>2024-05-04_18-55-46</td>\n",
       "      <td>['SCLC']</td>\n",
       "      <td>Lung/Thoracic</td>\n",
       "      <td>['METASTATIC', 'LOCAL']</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                               doi     date  \\\n",
       "492  10.1016/S1470-2045(19)30326-2   8/1/19   \n",
       "495          10.1056/NEJMoa2115022  3/24/22   \n",
       "496  10.1016/S1470-2045(18)30448-0  10/1/18   \n",
       "497          10.1056/NEJMoa2005493  9/17/20   \n",
       "499  10.1016/S1470-2045(16)30104-8   8/1/16   \n",
       "\n",
       "                                                 title  \\\n",
       "492  NBTXR3, a first-in-class radioenhancer hafnium...   \n",
       "495  Trastuzumab Deruxtecan versus Trastuzumab Emta...   \n",
       "496  Near-infrared fluorescence for detection of se...   \n",
       "497  Five-Year Analysis of Adjuvant Dabrafenib plus...   \n",
       "499  Combined chemotherapy with cisplatin, etoposid...   \n",
       "\n",
       "                                              abstract  \\\n",
       "492  BACKGROUND: Pathological complete response to ...   \n",
       "495  BACKGROUND: Trastuzumab emtansine is the curre...   \n",
       "496  BACKGROUND: Accurate identification of sentine...   \n",
       "497  BACKGROUND: In the previously reported primary...   \n",
       "499  BACKGROUND: Etoposide and irinotecan are key d...   \n",
       "\n",
       "                                  abstract_conclusions  \\\n",
       "492  INTERPRETATION: This trial validates the mode ...   \n",
       "495  CONCLUSIONS: Among patients with HER2-positive...   \n",
       "496  INTERPRETATION: Indocyanine green dye with nea...   \n",
       "497  CONCLUSIONS: In the 5-year follow-up of a phas...   \n",
       "499  INTERPRETATION: Combination chemotherapy with ...   \n",
       "\n",
       "                                 abstract_introduction  \\\n",
       "492  BACKGROUND: Pathological complete response to ...   \n",
       "495  BACKGROUND: Trastuzumab emtansine is the curre...   \n",
       "496  BACKGROUND: Accurate identification of sentine...   \n",
       "497  BACKGROUND: In the previously reported primary...   \n",
       "499  BACKGROUND: Etoposide and irinotecan are key d...   \n",
       "\n",
       "                                      abstract_methods  \\\n",
       "492  METHODS: Act.In.Sarc is a phase 2-3 randomised...   \n",
       "495  METHODS: We conducted a phase 3, multicenter, ...   \n",
       "496  METHODS: In this non-inferiority, within-patie...   \n",
       "497  METHODS: We randomly assigned 870 patients who...   \n",
       "499  METHODS: We did this open-label, multicentre, ...   \n",
       "\n",
       "                                      abstract_results  \\\n",
       "492  FINDINGS: Between March 3, 2015, and Nov 21, 2...   \n",
       "495  RESULTS: Among 524 randomly assigned patients,...   \n",
       "496  FINDINGS: Between Dec 21, 2015, and June 19, 2...   \n",
       "497  RESULTS: The minimum duration of follow-up was...   \n",
       "499  FINDINGS: Between Sept 20, 2007, and Nov 30, 2...   \n",
       "\n",
       "                                                  text  _input_hash  ...  \\\n",
       "492  NBTXR3, a first-in-class radioenhancer hafnium...    833943430  ...   \n",
       "495  Trastuzumab Deruxtecan versus Trastuzumab Emta...   -362049598  ...   \n",
       "496  Near-infrared fluorescence for detection of se...  -1854340481  ...   \n",
       "497  Five-Year Analysis of Adjuvant Dabrafenib plus...    800185485  ...   \n",
       "499  Combined chemotherapy with cisplatin, etoposid...    373127467  ...   \n",
       "\n",
       "                                               options _view_id  \\\n",
       "492  [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "495  [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "496  [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "497  [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "499  [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "\n",
       "                           config  answer  _timestamp        _annotator_id  \\\n",
       "492  {'choice_style': 'multiple'}  accept  1714942341  2024-05-05_22-27-48   \n",
       "495  {'choice_style': 'multiple'}  accept  1714933145  2024-05-05_10-26-22   \n",
       "496  {'choice_style': 'multiple'}  accept  1714941168  2024-05-05_22-27-48   \n",
       "497  {'choice_style': 'multiple'}  accept  1714941157  2024-05-05_22-27-48   \n",
       "499  {'choice_style': 'multiple'}  accept  1714844497  2024-05-04_18-55-46   \n",
       "\n",
       "             _session_id                 tumor_type                family  \\\n",
       "492  2024-05-05_22-27-48                ['Sarcoma']      Skin/Soft tissue   \n",
       "495  2024-05-05_10-26-22                 ['Breast']  Breast/Gynecological   \n",
       "496  2024-05-05_22-27-48  ['Cervix', 'Endometrial']  Breast/Gynecological   \n",
       "497  2024-05-05_22-27-48               ['Melanoma']      Skin/Soft tissue   \n",
       "499  2024-05-04_18-55-46                   ['SCLC']         Lung/Thoracic   \n",
       "\n",
       "                      accept  \n",
       "492                ['LOCAL']  \n",
       "495           ['METASTATIC']  \n",
       "496                ['LOCAL']  \n",
       "497                ['LOCAL']  \n",
       "499  ['METASTATIC', 'LOCAL']  \n",
       "\n",
       "[5 rows x 21 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Alle ASCO-Papers rausfiltern (alle die \"JCO\" in der doi haben) \n",
    "# Das ~ macht die verneninung\n",
    "filtermask = ~full[\"doi\"].str.contains(\"JCO\")\n",
    "full_noJCO = full[filtermask]\n",
    "full_noJCO.head()\n",
    "full_noJCO.tail()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "68ac42d1-461f-4fc2-aa89-68aa866c622d",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Zufallszahl generieren\n",
    "x = np.random.seed(86)\n",
    "#200 Einträge zufällig auswählen\n",
    "random200_noJCO = full_noJCO.sample(n = 200, random_state = x)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "75302b95-ba23-4e5e-8022-206fde9520d1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>doi</th>\n",
       "      <th>date</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>abstract_conclusions</th>\n",
       "      <th>abstract_introduction</th>\n",
       "      <th>abstract_methods</th>\n",
       "      <th>abstract_results</th>\n",
       "      <th>text</th>\n",
       "      <th>_input_hash</th>\n",
       "      <th>...</th>\n",
       "      <th>options</th>\n",
       "      <th>_view_id</th>\n",
       "      <th>config</th>\n",
       "      <th>answer</th>\n",
       "      <th>_timestamp</th>\n",
       "      <th>_annotator_id</th>\n",
       "      <th>_session_id</th>\n",
       "      <th>tumor_type</th>\n",
       "      <th>family</th>\n",
       "      <th>accept</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>10.1056/NEJMoa2304875</td>\n",
       "      <td>11/2/23</td>\n",
       "      <td>Perioperative Durvalumab for Resectable Non-Sm...</td>\n",
       "      <td>BACKGROUND: Neoadjuvant or adjuvant immunother...</td>\n",
       "      <td>CONCLUSIONS: In patients with resectable NSCLC...</td>\n",
       "      <td>BACKGROUND: Neoadjuvant or adjuvant immunother...</td>\n",
       "      <td>METHODS: We randomly assigned patients with re...</td>\n",
       "      <td>RESULTS: A total of 802 patients were randomly...</td>\n",
       "      <td>Perioperative Durvalumab for Resectable Non-Sm...</td>\n",
       "      <td>-150113581</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1715066023</td>\n",
       "      <td>2024-05-07_08-44-05</td>\n",
       "      <td>2024-05-07_08-44-05</td>\n",
       "      <td>['NSCLC']</td>\n",
       "      <td>Lung/Thoracic</td>\n",
       "      <td>['LOCAL']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>10.1056/NEJMoa1817323</td>\n",
       "      <td>7/25/19</td>\n",
       "      <td>Erdafitinib in Locally Advanced or Metastatic ...</td>\n",
       "      <td>BACKGROUND: Alterations in the gene encoding f...</td>\n",
       "      <td>CONCLUSIONS: The use of erdafitinib was associ...</td>\n",
       "      <td>BACKGROUND: Alterations in the gene encoding f...</td>\n",
       "      <td>METHODS: In this open-label, phase 2 study, we...</td>\n",
       "      <td>RESULTS: A total of 99 patients in the selecte...</td>\n",
       "      <td>Erdafitinib in Locally Advanced or Metastatic ...</td>\n",
       "      <td>-1415990899</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1714933654</td>\n",
       "      <td>2024-05-05_10-26-22</td>\n",
       "      <td>2024-05-05_10-26-22</td>\n",
       "      <td>['Urothelia', 'General metastases']</td>\n",
       "      <td>Urogenital</td>\n",
       "      <td>['LOCAL', 'METASTATIC']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324</th>\n",
       "      <td>10.1016/S0140-6736(15)01283-0</td>\n",
       "      <td>4/16/16</td>\n",
       "      <td>Eribulin versus dacarbazine in previously trea...</td>\n",
       "      <td>BACKGROUND: A non-randomised, phase 2 study sh...</td>\n",
       "      <td>INTERPRETATION: Overall survival was improved ...</td>\n",
       "      <td>BACKGROUND: A non-randomised, phase 2 study sh...</td>\n",
       "      <td>METHODS: We did this randomised, open-label, p...</td>\n",
       "      <td>FINDINGS: Between March 10, 2011 and May 22, 2...</td>\n",
       "      <td>Eribulin versus dacarbazine in previously trea...</td>\n",
       "      <td>425218450</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1714943701</td>\n",
       "      <td>2024-05-05_22-27-48</td>\n",
       "      <td>2024-05-05_22-27-48</td>\n",
       "      <td>['Sarcoma']</td>\n",
       "      <td>Skin/Soft tissue</td>\n",
       "      <td>['LOCAL', 'METASTATIC']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>10.1016/S1470-2045(13)70363-2</td>\n",
       "      <td>9/1/13</td>\n",
       "      <td>Long-term results of dose-dense paclitaxel and...</td>\n",
       "      <td>BACKGROUND: The primary analysis of the JGOG 3...</td>\n",
       "      <td>INTERPRETATION: Dose-dense treatment offers be...</td>\n",
       "      <td>BACKGROUND: The primary analysis of the JGOG 3...</td>\n",
       "      <td>METHODS: This randomised controlled trial was ...</td>\n",
       "      <td>FINDINGS: 637 patients were enrolled, of whom ...</td>\n",
       "      <td>Long-term results of dose-dense paclitaxel and...</td>\n",
       "      <td>441337025</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1715064538</td>\n",
       "      <td>2024-05-07_08-44-05</td>\n",
       "      <td>2024-05-07_08-44-05</td>\n",
       "      <td>['Ovary']</td>\n",
       "      <td>Breast/Gynecological</td>\n",
       "      <td>['LOCAL', 'METASTATIC']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>457</th>\n",
       "      <td>10.1001/jamaoncol.2018.3039</td>\n",
       "      <td>11/1/18</td>\n",
       "      <td>Effect of Anlotinib as a Third-Line or Further...</td>\n",
       "      <td>IMPORTANCE: Anlotinib is a novel multitarget t...</td>\n",
       "      <td>CONCLUSIONS AND RELEVANCE: Among the Chinese p...</td>\n",
       "      <td>IMPORTANCE: Anlotinib is a novel multitarget t...</td>\n",
       "      <td>DESIGN, SETTING, AND PARTICIPANTS: The ALTER 0...</td>\n",
       "      <td>RESULTS: In total, 439 patients were randomize...</td>\n",
       "      <td>Effect of Anlotinib as a Third-Line or Further...</td>\n",
       "      <td>1312225533</td>\n",
       "      <td>...</td>\n",
       "      <td>[{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...</td>\n",
       "      <td>choice</td>\n",
       "      <td>{'choice_style': 'multiple'}</td>\n",
       "      <td>accept</td>\n",
       "      <td>1714843248</td>\n",
       "      <td>2024-05-04_18-55-46</td>\n",
       "      <td>2024-05-04_18-55-46</td>\n",
       "      <td>['NSCLC']</td>\n",
       "      <td>Lung/Thoracic</td>\n",
       "      <td>['METASTATIC', 'LOCAL']</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                               doi     date  \\\n",
       "233          10.1056/NEJMoa2304875  11/2/23   \n",
       "65           10.1056/NEJMoa1817323  7/25/19   \n",
       "324  10.1016/S0140-6736(15)01283-0  4/16/16   \n",
       "270  10.1016/S1470-2045(13)70363-2   9/1/13   \n",
       "457    10.1001/jamaoncol.2018.3039  11/1/18   \n",
       "\n",
       "                                                 title  \\\n",
       "233  Perioperative Durvalumab for Resectable Non-Sm...   \n",
       "65   Erdafitinib in Locally Advanced or Metastatic ...   \n",
       "324  Eribulin versus dacarbazine in previously trea...   \n",
       "270  Long-term results of dose-dense paclitaxel and...   \n",
       "457  Effect of Anlotinib as a Third-Line or Further...   \n",
       "\n",
       "                                              abstract  \\\n",
       "233  BACKGROUND: Neoadjuvant or adjuvant immunother...   \n",
       "65   BACKGROUND: Alterations in the gene encoding f...   \n",
       "324  BACKGROUND: A non-randomised, phase 2 study sh...   \n",
       "270  BACKGROUND: The primary analysis of the JGOG 3...   \n",
       "457  IMPORTANCE: Anlotinib is a novel multitarget t...   \n",
       "\n",
       "                                  abstract_conclusions  \\\n",
       "233  CONCLUSIONS: In patients with resectable NSCLC...   \n",
       "65   CONCLUSIONS: The use of erdafitinib was associ...   \n",
       "324  INTERPRETATION: Overall survival was improved ...   \n",
       "270  INTERPRETATION: Dose-dense treatment offers be...   \n",
       "457  CONCLUSIONS AND RELEVANCE: Among the Chinese p...   \n",
       "\n",
       "                                 abstract_introduction  \\\n",
       "233  BACKGROUND: Neoadjuvant or adjuvant immunother...   \n",
       "65   BACKGROUND: Alterations in the gene encoding f...   \n",
       "324  BACKGROUND: A non-randomised, phase 2 study sh...   \n",
       "270  BACKGROUND: The primary analysis of the JGOG 3...   \n",
       "457  IMPORTANCE: Anlotinib is a novel multitarget t...   \n",
       "\n",
       "                                      abstract_methods  \\\n",
       "233  METHODS: We randomly assigned patients with re...   \n",
       "65   METHODS: In this open-label, phase 2 study, we...   \n",
       "324  METHODS: We did this randomised, open-label, p...   \n",
       "270  METHODS: This randomised controlled trial was ...   \n",
       "457  DESIGN, SETTING, AND PARTICIPANTS: The ALTER 0...   \n",
       "\n",
       "                                      abstract_results  \\\n",
       "233  RESULTS: A total of 802 patients were randomly...   \n",
       "65   RESULTS: A total of 99 patients in the selecte...   \n",
       "324  FINDINGS: Between March 10, 2011 and May 22, 2...   \n",
       "270  FINDINGS: 637 patients were enrolled, of whom ...   \n",
       "457  RESULTS: In total, 439 patients were randomize...   \n",
       "\n",
       "                                                  text  _input_hash  ...  \\\n",
       "233  Perioperative Durvalumab for Resectable Non-Sm...   -150113581  ...   \n",
       "65   Erdafitinib in Locally Advanced or Metastatic ...  -1415990899  ...   \n",
       "324  Eribulin versus dacarbazine in previously trea...    425218450  ...   \n",
       "270  Long-term results of dose-dense paclitaxel and...    441337025  ...   \n",
       "457  Effect of Anlotinib as a Third-Line or Further...   1312225533  ...   \n",
       "\n",
       "                                               options _view_id  \\\n",
       "233  [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "65   [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "324  [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "270  [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "457  [{'id': 'LOCAL', 'text': 'LOCAL'}, {'id': 'MET...   choice   \n",
       "\n",
       "                           config  answer  _timestamp        _annotator_id  \\\n",
       "233  {'choice_style': 'multiple'}  accept  1715066023  2024-05-07_08-44-05   \n",
       "65   {'choice_style': 'multiple'}  accept  1714933654  2024-05-05_10-26-22   \n",
       "324  {'choice_style': 'multiple'}  accept  1714943701  2024-05-05_22-27-48   \n",
       "270  {'choice_style': 'multiple'}  accept  1715064538  2024-05-07_08-44-05   \n",
       "457  {'choice_style': 'multiple'}  accept  1714843248  2024-05-04_18-55-46   \n",
       "\n",
       "             _session_id                           tumor_type  \\\n",
       "233  2024-05-07_08-44-05                            ['NSCLC']   \n",
       "65   2024-05-05_10-26-22  ['Urothelia', 'General metastases']   \n",
       "324  2024-05-05_22-27-48                          ['Sarcoma']   \n",
       "270  2024-05-07_08-44-05                            ['Ovary']   \n",
       "457  2024-05-04_18-55-46                            ['NSCLC']   \n",
       "\n",
       "                   family                   accept  \n",
       "233         Lung/Thoracic                ['LOCAL']  \n",
       "65             Urogenital  ['LOCAL', 'METASTATIC']  \n",
       "324      Skin/Soft tissue  ['LOCAL', 'METASTATIC']  \n",
       "270  Breast/Gynecological  ['LOCAL', 'METASTATIC']  \n",
       "457         Lung/Thoracic  ['METASTATIC', 'LOCAL']  \n",
       "\n",
       "[5 rows x 21 columns]"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Anfang der Tabelle zeigen (schauen ob das mit dem immer gleichen Zufall klappt (250, 236))\n",
    "random200_noJCO.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "06cf453d-4d26-4c21-a048-06c03ab0167f",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Excelfile (.csv Format, nicht.xlsx) erstellen mit den 200 zufälligen Papers\n",
    "random200_noJCO.to_csv(\"C:/Users/Julia/Desktop/Masterarbeit/Full Dataset/metastatic_local_random200_noJCO.csv\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "211f7c61-1d42-41da-b916-eed2497a32cd",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "dbd946a6-fea2-4e4e-b7b6-5d343e8a9370",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
